D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$939M |
| 2 |
Netflix
NFLX
|
+$838M |
| 3 |
Micron Technology
MU
|
+$490M |
| 4 |
Affirm
AFRM
|
+$417M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$399M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$356M |
| 5 |
UnitedHealth
UNH
|
+$299M |
Sector Composition
| 1 | Technology | 28.8% |
| 2 | Consumer Discretionary | 15.68% |
| 3 | Healthcare | 9.51% |
| 4 | Financials | 8.37% |
| 5 | Communication Services | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
BridgeBio Pharma
BBIO
$10.4B
| $37.3M | 0.03% |
924,865
-416,378
| -31% | -$16.8M |
|
302
Kyndryl
KD
$7.66B
| $37.2M | 0.03% |
1,791,302
-218,126
| -11% | -$4.53M |
|
303
Teradyne
TER
$18.9B
| $37.1M | 0.03% |
342,219
-480,813
| -58% | -$52.2M |
|
304
PTC Therapeutics
PTCT
$4.52B
| $37.1M | 0.03% |
1,346,967
+506,158
| +60% | +$13.9M |
|
305
Ollie's Bargain Outlet
OLLI
$8.12B
| $36.9M | 0.03% |
486,430
+264,655
| +119% | +$20.1M |
|
|
ITCI
306
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $36.6M | 0.03% |
511,550
-229,827
| -31% | -$16.5M |
|
|
RBCP
307
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $36.3M | 0.03% |
280,000
| – | – |
|
308
Moderna
MRNA
$9.66B
| $36M | 0.03% |
362,177
+303,845
| +521% | +$30.2M |
|
309
Marriott Vacations Worldwide
VAC
$2.71B
| $35.9M | 0.03% |
423,408
+260,776
| +160% | +$22.1M |
|
|
MDRX
310
DELISTED
Veradigm Inc. Common Stock
MDRX
| $35.7M | 0.03% |
3,398,754
-235,484
| -6% | -$2.47M |
|
311
Colgate-Palmolive
CL
$68B
| $35.4M | 0.03% |
444,709
-515,507
| -54% | -$41.1M |
|
312
Outfront Media
OUT
$3.17B
| $34.9M | 0.03% |
2,539,938
+521,474
| +26% | +$7.17M |
|
|
TGI
313
DELISTED
Triumph Group
TGI
| $34.5M | 0.03% |
2,082,631
+983,532
| +89% | +$16.3M |
|
314
Myriad Genetics
MYGN
$643M
| $34.5M | 0.03% |
1,801,306
-376,619
| -17% | -$7.21M |
|
315
Nuvalent
NUVL
$5.76B
| $34.5M | 0.03% |
468,183
+150,907
| +48% | +$11.1M |
|
316
NETSCOUT
NTCT
$1.78B
| $34.4M | 0.03% |
1,565,484
+321,802
| +26% | +$7.06M |
|
317
Sarepta Therapeutics
SRPT
$1.84B
| $34.3M | 0.03% |
355,533
+263,375
| +286% | +$25.4M |
|
318
Centene
CNC
$14.2B
| $33.9M | 0.03% |
456,769
-683,198
| -60% | -$50.7M |
|
319
Coterra Energy
CTRA
$18.2B
| $33.8M | 0.03% |
+1,323,917
| New | +$33.8M |
|
320
Nextracker
NXT
$10.3B
| $33.8M | 0.03% |
720,731
+130,789
| +22% | +$6.13M |
|
321
Altice USA
ATUS
$1.05B
| $33.6M | 0.03% |
10,327,358
+5,738,727
| +125% | +$18.7M |
|
322
Ascendis Pharma
ASND
$12.4B
| $33.4M | 0.03% |
265,157
+44,604
| +20% | +$5.62M |
|
323
Paychex
PAYX
$48.7B
| $33.4M | 0.03% |
280,281
-282,791
| -50% | -$33.7M |
|
324
AutoNation
AN
$8.57B
| $33.3M | 0.03% |
221,447
-46,809
| -17% | -$7.03M |
|
325
PROG Holdings
PRG
$1.4B
| $33.2M | 0.03% |
1,074,499
-20,284
| -2% | -$627K |
|